Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US

This cross-sectional study assesses the availability of buprenorphine for opioid use disorder treatment at local pharmacies in the US by state and retail pharmacy chain.

Detalles Bibliográficos
Autores principales: Weiner, Scott G., Qato, Dima M., Faust, Jeremy Samuel, Clear, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220511/
https://www.ncbi.nlm.nih.gov/pubmed/37234009
http://dx.doi.org/10.1001/jamanetworkopen.2023.16089
_version_ 1785049235250479104
author Weiner, Scott G.
Qato, Dima M.
Faust, Jeremy Samuel
Clear, Brian
author_facet Weiner, Scott G.
Qato, Dima M.
Faust, Jeremy Samuel
Clear, Brian
author_sort Weiner, Scott G.
collection PubMed
description This cross-sectional study assesses the availability of buprenorphine for opioid use disorder treatment at local pharmacies in the US by state and retail pharmacy chain.
format Online
Article
Text
id pubmed-10220511
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-102205112023-05-28 Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US Weiner, Scott G. Qato, Dima M. Faust, Jeremy Samuel Clear, Brian JAMA Netw Open Research Letter This cross-sectional study assesses the availability of buprenorphine for opioid use disorder treatment at local pharmacies in the US by state and retail pharmacy chain. American Medical Association 2023-05-26 /pmc/articles/PMC10220511/ /pubmed/37234009 http://dx.doi.org/10.1001/jamanetworkopen.2023.16089 Text en Copyright 2023 Weiner SG et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
Weiner, Scott G.
Qato, Dima M.
Faust, Jeremy Samuel
Clear, Brian
Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
title Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
title_full Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
title_fullStr Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
title_full_unstemmed Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
title_short Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
title_sort pharmacy availability of buprenorphine for opioid use disorder treatment in the us
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220511/
https://www.ncbi.nlm.nih.gov/pubmed/37234009
http://dx.doi.org/10.1001/jamanetworkopen.2023.16089
work_keys_str_mv AT weinerscottg pharmacyavailabilityofbuprenorphineforopioidusedisordertreatmentintheus
AT qatodimam pharmacyavailabilityofbuprenorphineforopioidusedisordertreatmentintheus
AT faustjeremysamuel pharmacyavailabilityofbuprenorphineforopioidusedisordertreatmentintheus
AT clearbrian pharmacyavailabilityofbuprenorphineforopioidusedisordertreatmentintheus

Ejemplares similares